Anti-FDSCP/ FDCSP/ C4orf7 functional antibody
Anti-FDSCP/ FDCSP/ C4orf7 functional antibody for cell culture, ELISA & in-vivo assay
Go to FDCSP/FDCSP products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE0214-Ab-1/ GM-Tg-hg-SE0214-Ab-2 | Anti-Human FDCSP monoclonal antibody | Human |
| GM-Tg-rg-SE0214-Ab-1/ GM-Tg-rg-SE0214-Ab-2 | Anti-Rat FDCSP monoclonal antibody | Rat |
| GM-Tg-mg-SE0214-Ab-1/ GM-Tg-mg-SE0214-Ab-2 | Anti-Mouse FDCSP monoclonal antibody | Mouse |
| GM-Tg-cynog-SE0214-Ab-1/ GM-Tg-cynog-SE0214-Ab-2 | Anti-Cynomolgus/ Rhesus macaque FDCSP monoclonal antibody | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE0214-Ab-1/ GM-Tg-felg-SE0214-Ab-2 | Anti-Feline FDCSP monoclonal antibody | Feline |
| GM-Tg-cang-SE0214-Ab-1/ GM-Tg-cang-SE0214-Ab-2 | Anti-Canine FDCSP monoclonal antibody | Canine |
| GM-Tg-bovg-SE0214-Ab-1/ GM-Tg-bovg-SE0214-Ab-2 | Anti-Bovine FDCSP monoclonal antibody | Bovine |
| GM-Tg-equg-SE0214-Ab-1/ GM-Tg-equg-SE0214-Ab-2 | Anti-Equine FDCSP monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. | GM-Tg-hg-SE0214-Ab-1/ GM-Tg-hg-SE0214-Ab-2; GM-Tg-rg-SE0214-Ab-1/ GM-Tg-rg-SE0214-Ab-2; GM-Tg-mg-SE0214-Ab-1/ GM-Tg-mg-SE0214-Ab-2; GM-Tg-cynog-SE0214-Ab-1/ GM-Tg-cynog-SE0214-Ab-2; GM-Tg-felg-SE0214-Ab-1/ GM-Tg-felg-SE0214-Ab-2; GM-Tg-cang-SE0214-Ab-1/ GM-Tg-cang-SE0214-Ab-2; GM-Tg-bovg-SE0214-Ab-1/ GM-Tg-bovg-SE0214-Ab-2; GM-Tg-equg-SE0214-Ab-1/ GM-Tg-equg-SE0214-Ab-2 |
| Products Name | Anti-FDCSP monoclonal antibody |
| Format | mab |
| Target Name | FDCSP |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category of antibody | FACS/Biofunctional Antibody |
| Derivation (species) | Mouse |
| CH1+2+3 Isotype (Receptor identification) | IgG |
| Type of Light Chain (VD-LC) | N/A |
| Expression platform | Mammalian Expression |
| Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
| Tag | Fc |
| Products description | Pre-made anti-FDCSP benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
| Target Antigen | GM-Tg-g-SE0214-Ag-1 | Recombinant multi-species FDSCP/ FDCSP/ C4orf7 protein |
Target information
| Target ID | GM-SE0214 |
| Target Name | FDCSP |
| Gene ID | 260436,494497,494224,707784,104968904,111772689 |
| Gene Symbol and Synonyms | BC037156,C4orf7,C5H4orf7,FDC-SP,FDCSP |
| Uniprot Accession | Q8NFU4 |
| Uniprot Entry Name | FDSCP_HUMAN |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | |
| Disease | N/A |
| Gene Ensembl | ENSG00000181617 |
| Target Classification | N/A |
The target: FDCSP, gene name: FDCSP, also named as C4orf7, FDC-SP. This gene encodes a small secreted protein that is expressed in follicular dendritic cells. This protein specifically binds to activated B cells, and functions as a regulator of antibody responses. It is also thought to contribute to tumor metastases by promoting cancer cell migration and invasion. [provided by RefSeq, Dec 2011].
About Gmab


GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.

